Phase out knockoff versions of Lilly obesity drug, FDA says

WASHINGTON, D.C.: The Food and Drug Administration (FDA) has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs Zepbound and Mounjaro, following the resolution of a nationwide shortage.

In a decision announced this week, the FDA stated that Lilly's supply of obesity and diabetes medications now meets or exceeds demand, eliminating the need for copyca